Unique Software Platform to Improve Medical Pathology Education and Collaboration
By LabMedica International staff writers Posted on 26 May 2014 |

Image: Efficient sharing of high-quality images with \"VENTANA Vector\" software for dynamic pathology training and collaboration (Photo courtesy of Ventana Medical Systems).
A new software platform provides a flexible digital pathology solution for more efficient and effective medical training courses and sharing of high-quality images.
Ventana Medical Systems, Inc. (Ventana; Tucson, AZ, USA), member of the Roche Group (Basel, Switzerland), has now released "VENTANA Vector," a new software platform for pathology training and collaboration. The platform provides pathologists and educators with tools to build interactive training, from course development to student evaluation, and to quickly and easily share scanned images with colleagues around the globe. The software is available anywhere, anytime, and is supported on a range of tablets and mobile devices.
This innovative software enhances the learning experience, engagement, and collaboration for students while providing efficiencies for educators. Whole slide imaging has gained tremendous acceptance within pathology education because of its many advantages over traditional teaching methods. Courses that use glass slides face several potential challenges such as slide breakage, periodic re-cutting, limited availability, and the inherent quality inconsistency of multiple slide sets. "Digital pathology is gaining widespread adoption for medical education and training. The release of VENTANA Vector software expands our Digital Pathology portfolio to address the growing needs of the pathology education market. The software will make pathology training more accurate and cost-effective, while empowering students with collaborative learning strategies," said Vikram Mohan, international business leader, Digital Pathology, Ventana.
Many medical schools are relying less and less on the light microscope as the primary teaching tool in pathology. VENTANA Vector software can help standardize training content by enabling students to view high quality, consistent slide images, and eliminate the frustration of having to share limited resources such as slide sets and multi-head microscopes. "Now we can pick the best slides, scan them, and use the same digital slide set for all students. They can all access the same teaching materials anytime from their computer, tablet, or smart phone," said Dr. Sung, professor of Pathology, Women & Infants Hospital (Providence, RI, USA).
The VENTANA Vector software platform is unique in the digital pathology market in offering a highly customizable interface, ability for users to view on mobile devices with both Cloud and local hosting options, and is fully compatible with iScan Coreo and VENTANA iScan HT slide scanners.
Related Links:
Ventana Medical Systems
Ventana Medical Systems, Inc. (Ventana; Tucson, AZ, USA), member of the Roche Group (Basel, Switzerland), has now released "VENTANA Vector," a new software platform for pathology training and collaboration. The platform provides pathologists and educators with tools to build interactive training, from course development to student evaluation, and to quickly and easily share scanned images with colleagues around the globe. The software is available anywhere, anytime, and is supported on a range of tablets and mobile devices.
This innovative software enhances the learning experience, engagement, and collaboration for students while providing efficiencies for educators. Whole slide imaging has gained tremendous acceptance within pathology education because of its many advantages over traditional teaching methods. Courses that use glass slides face several potential challenges such as slide breakage, periodic re-cutting, limited availability, and the inherent quality inconsistency of multiple slide sets. "Digital pathology is gaining widespread adoption for medical education and training. The release of VENTANA Vector software expands our Digital Pathology portfolio to address the growing needs of the pathology education market. The software will make pathology training more accurate and cost-effective, while empowering students with collaborative learning strategies," said Vikram Mohan, international business leader, Digital Pathology, Ventana.
Many medical schools are relying less and less on the light microscope as the primary teaching tool in pathology. VENTANA Vector software can help standardize training content by enabling students to view high quality, consistent slide images, and eliminate the frustration of having to share limited resources such as slide sets and multi-head microscopes. "Now we can pick the best slides, scan them, and use the same digital slide set for all students. They can all access the same teaching materials anytime from their computer, tablet, or smart phone," said Dr. Sung, professor of Pathology, Women & Infants Hospital (Providence, RI, USA).
The VENTANA Vector software platform is unique in the digital pathology market in offering a highly customizable interface, ability for users to view on mobile devices with both Cloud and local hosting options, and is fully compatible with iScan Coreo and VENTANA iScan HT slide scanners.
Related Links:
Ventana Medical Systems
Latest Pathology News
- Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
- Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
- Image-Based AI Shows Promise for Parasite Detection in Digitized Stool Samples
- Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy
- Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities
- Virtual Skin Biopsy Determines Presence of Cancerous Cells
- AI Detects Viable Tumor Cells for Accurate Bone Cancer Prognoses Post Chemotherapy
- First Ever Technique Identifies Single Cancer Cells in Blood for Targeted Treatments
- Innovative Blood Collection Device Overcomes Common Obstacles Related to Phlebotomy
- Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes
- Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases
- Bioinformatics Tool to Identify Chromosomal Alterations in Tumor Cells Can Improve Cancer Diagnosis
- Coin-Sized Device Rapidly Isolates Blood Plasma for Quicker and More Precise Clinical Diagnoses
- AI Predicts Cancer Spreading To Brain from Lung Biopsy Images
- Improved Microneedle Technology Speeds Up Extraction of Sample Interstitial Fluid for Disease Diagnosis
- AI Outperforms Expert Pathologists in Predicting Lung Cancer Spread
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg)
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read moreMolecular Diagnostics
view channel
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read moreHematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Mouth Bacteria Test Could Predict Colon Cancer Progression
Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more.jpg)
Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
Sepsis is a life-threatening condition triggered by an extreme response of the body to an infection. It requires immediate medical intervention to prevent potential death or lasting damage.... Read moreTechnology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
ECCMID Congress Name Changes to ESCMID Global
Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more
Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
Given the presence of so many diseases, determining whether a patient is presenting the symptoms of a simple cold, the flu, or something as severe as life-threatening meningitis is usually only possible... Read more